teclistamab
janssen,genmab
['mmsm', 'teclistamab', 'majestec-1']
look forward to #asco22 presentation #multiplemyeloma #mmsm nct04557098: phase 2- teclistamab, in participants with relapsed or refractory myeloma (majestec-1) 
Multiple Myeloma Education Platform for Myeloma Community